SJ, F., A, R., M, T., J, B., M, W., D, R., . . . JI, I. (2026). Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer. Advances in therapy. https://doi.org/10.1007/s12325-026-03624-1
Chicago Style (17th ed.) CitationSJ, Freedland, Ribbands A, Touya M, Butcher J, Walley M, Russell D, Bland CS, and Ivanova JI. "Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer." Advances in Therapy 2026. https://doi.org/10.1007/s12325-026-03624-1.
MLA (9th ed.) CitationSJ, Freedland, et al. "Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer." Advances in Therapy, 2026, https://doi.org/10.1007/s12325-026-03624-1.